-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2021qdr-appendixes.pdf
December 01, 2021 - Health Services Administration
• National Survey on Drug Use and Health (NSDUH)
• Substance Use Disorder
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol1/Advances-Emanuel-Berwick_110.pdf
July 02, 2008 - The practitioner was trained and certified to apply
therapy at the point of the illness-causing disorder
-
www.ahrq.gov/research/findings/nhqrdr/chartbooks/carecoordination/carecoordination-slides.html
June 01, 2018 - Chartbook on Care Coordination: Slide Presentation
National Healthcare Quality and Disparities Report
Slide 1
National Healthcare Quality and Disparities Report
Chartbook on Care Coordination
June 2016
Slide 2
National Healthcare Quality and Disparities Report
Annual report to Congress mandat…
-
www.ahrq.gov/sites/default/files/2024-05/gore-report.pdf
January 01, 2024 - urinary incontinence, COPD requiring home oxygen, type 2 diabetes,
obstructive sleep apnea, a seizure disorder
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-150-fullreport.pdf
February 14, 2018 - Metabolic Monitoring for Children and Adolescents on Antipsychotics
1
Metabolic Monitoring for Children and Adolescents
on Antipsychotics
Section 1. Basic Measure Information
1.A. Measure Name
Metabolic Monitoring for Children and Adolescents on Antipsychotics
1.B. Measure Number
0150
1.C. Measure Descripti…
-
www.ahrq.gov/sites/default/files/2025-03/joo-report.pdf
January 01, 2025 - Final Progress Report: Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)
1. Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma
(REDEFINE Study)
Principal Investigator and Team Members/Organization:
Min J. Joo, MD, MPH, Department of Medicine, College of Medi…
-
www.ahrq.gov/research/findings/final-reports/iomracereport/reldata4c.html
August 01, 2021 - Race, Ethnicity, and Language Data: Standardization for Health Care Quality Improvement
Chapter 4: Defining Language Need and Categories for Collection, cont.
Previous Page Next Page
Table of Contents
Race, Ethnicity, and Language Data: Standardization for Health Care Quality Improvement
Summary
…
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/Kenyon2014.pdf
February 01, 2014 - Rehospitalization for Childhood Asthma: Timing, Variation, and Opportunities for Intervention
Rehospitalization for Childhood Asthma: Timing, Variation, and
Opportunities for Intervention
Ch�en C. Kenyon, MD1,2, Patrice R. Melvin, MPH3, Vincent W. Chiang, MD2,4, Marc N. Elliott, PhD5,
Mark A. Schuster, MD, PhD2,4, …
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Encinosa.pdf
January 01, 2003 - What Happens After a Patient Safety Event? Medical Expenditures and Outcomes in Medicare
423
What Happens After a Patient Safety Event?
Medical Expenditures and Outcomes
in Medicare
William E. Encinosa, Fred J. Hellinger
Abstract
Objective: To estimate the impact of potentially preventable adverse event…
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol3/Advances-Zierler_81.pdf
September 01, 2008 - Venous Thromboembolism Safety Toolkit: A Systems Approach to Patient Safety
Venous Thromboembolism Safety Toolkit:
A Systems Approach to Patient Safety
Brenda K. Zierler, PhD; Ann Wittkowsky, PharmD; Gene Peterson, MD, PhD;
Jung-Ah Lee, MN; Courtney Jacobson, BA; Robb Glenny, MD; Fred Wolf, PhD;
Lynne Robin…
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/delirium-1.pdf
March 01, 2020 - Making Healthcare Safer Practices: 14. Delirium
Delirium 14-1
14. Delirium
Authors: Lynn Hoffman M.A., M.P.H., Aline Holmes D.N.P., R.N., Jennifer Riggs, Ph.D., R.N., and
Stephanie Schneiderman, M.P.P.
Introduction
Patient safety research and quality improvement efforts have been underway in the delirium harm …
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/pubs/background-2012/backgrnd2012.pdf
January 01, 2012 - Key: ADHD = attention deficit/hyperactivity disorder; AHRQ = Agency for Healthcare Research and Quality
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/chipra-factors-influencing-state-reporting.pdf
July 01, 2016 - m
Follow-up care for children prescribed attention-deficit/hyperactivity Administrative m • • •
disorder
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/chipra-primary-care-physician-reporting.pdf
December 01, 2016 - department
visits for asthma, and medication follow-up visits for attention deficit-hyperactivity disorder
-
www.ahrq.gov/sites/default/files/publications2/files/building-state-cooperatives-meeting-summary.pdf
September 26, 2024 - Much of her current
research focuses on improving the quality of substance use disorder treatment for
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2019qdr-intro-methods-cx061721.pdf
December 01, 2020 - Health Services Administration
• National Survey on Drug Use and Health (NSDUH)
• Substance Use Disorder
-
www.ahrq.gov/sites/default/files/wysiwyg/funding/training-grants/kaward/kaward-evalreport.pdf
August 01, 2016 - AHRQ Individual Research Career Development (K) Award Program
AGENCY FOR HEALTHCARE
RESEARCH AND QUALITY
INDIVIDUAL RESEARCH CAREER
DEVELOPMENT (K) AWARD PROGRAM
Evaluation Report
Evaluation Report
Agency for Healthcare Research and Quality
Individual Career Development (K) Award Program
Prepa…
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/anticoagulants-1.pdf
March 01, 2020 - Chapter-7 - Harm Due to Anticoagulants
Harms Due to Anticoagulants 7-1
7. Harms Due to Anticoagulants
Authors: Sarah J. Shoemaker-Hunt, Ph.D., Pharm.D., and Brandy Wyant, M.P.H.
Introduction
Anticoagulants are a critical therapy in the prevention and treatment of various types of
thromboembolic disorders. Key in…
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/NCINQTobaccoUseHelpForm.pdf
August 01, 2012 - chronic conditions across the sites were: 1) asthma;
2) depression; 3) attention deficient hyperactivity disorder
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA0087-NCINQSexualActivityStatusForm.pdf
February 06, 2012 - chronic conditions across the sites were: 1)
asthma; 2) depression; 3) attention deficient hyperactivity disorder